Cargando…
The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review
Approximately 1.5 million people in the United States currently identify as transgender. The use of gender affirming hormone therapy is integral to routine clinical care of transgender individuals, yet our understanding of the effects of this therapy is limited. There are reasons to believe that gen...
Autores principales: | Chan Swe, Nyein, Ahmed, Samihah, Eid, Marwen, Poretsky, Leonid, Gianos, Eugenia, Cusano, Natalie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907681/ https://www.ncbi.nlm.nih.gov/pubmed/35282421 http://dx.doi.org/10.1016/j.metop.2022.100173 |
Ejemplares similares
-
Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment
por: Masumori, Naoya, et al.
Publicado: (2023) -
Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021) -
Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
por: Connelly, Paul J., et al.
Publicado: (2019) -
Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy
por: Sánchez-Toscano, Esteban, et al.
Publicado: (2023) -
THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor
por: Ahmed, Samihah, et al.
Publicado: (2023)